United States · FDA National Drug Code directory
Guaifenesin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69842-335_4653e896-cfea-4625-e063-6394a90a4c7f
- Product NDC
- 69842-335
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Guaifenesin
- Labeler
- CVS PHARMACY, INC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210301
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 1200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (69842-335-16) · 69842-335-16
- 28 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (69842-335-28) · 69842-335-28
- 42 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (69842-335-42) · 69842-335-42
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →